Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Fibrocell Science to begin phase II azficel-T trial for restrictive burn scars

Dec. 18, 2012

New phase IIb study of Zorcell psoriasis vaccine begins

Dec. 13, 2012

Anacor discloses results from phase II trial of AN-2728

Dec. 13, 2012

Janssen Biotech and Janssen Biologics seek additional approvals for Stelara

Dec. 10, 2012

RXi Pharmaceuticals begins second phase I study of anti-scarring drug

Dec. 7, 2012

Kythera's ATX-101 is safe in interim study results

Nov. 30, 2012

Botox approved for severe primary axillary hyperhidrosis in Japan

Nov. 22, 2012

LEO Pharma's Picato gel receives European approval for actinic keratosis

Nov. 21, 2012

RXi reports pharmacokinetic results from phase I study of candidate for dermal scarring

Nov. 16, 2012

Novel ACAT inhibitors disclosed by Pierre Fabre Medicament

Nov. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...